The rise of AI and its impact on healthcare evoked thoughtful discussions at our 6th HealthcareInsider Expert Roundtable held on 12 July to the theme of “Healthcare 2.0: Unleashing the Power of Disruptive Innovations”.
IHH Group CFO Joerg Ayrle moderated the conversation at this hybrid event with an expert panel comprising IHH Group Head of Innovation Elizabeth Han, Founder and CEO of Doctor Anywhere Lim Wai Mun, and Co-founder and CEO of Us2.ai James Hare.
“One of the great things is that technology is a great leveller, and that’s the reason we invest so much in it. It allows systems like IHH to really expand and push beyond the four walls of our hospitals and clinics and reach people who may not be our patients today,” said Elizabeth Han, IHH Group Head of Innovation.
Tapping onto our Innovation Fund, we invest in and partner with novel and potentially disruptive companies in digital health and tech-enabled healthcare services to expand IHH’s capabilities and grow our healthcare ecosystem.
Big thanks also to Sherie Ng, Country Director, Google Cloud, Singapore and Google Singapore for hosting the event and sharing about Google’s suite of innovative products in the healthcare space.
Related Stories
Fortis Hospitals Win Prestigious Awards at 12th International Patient Safety Conference
From Data to Action! IHH Malaysia's Game-Changing Approach With New Operations Command Centre
Breaking New Ground as Mount Elizabeth Orchard Unveils Next-Level Diagnostic & Imaging Centre
Fortis Hospital Shalimar Bagh Champions Gender Equality with Walkathon
Advancing Treatment for Pulmonary Arterial Hypertension: An Approach with Sotatercept
A development in Pulmonary Arterial Hypertension (PAH) treatment took place at Mount Elizabeth Hospital, Singapore, where a patient received Sotatercept — a therapy that offers additional possibilities for managing this complex condition. This reflects ongoing progress in cardiology and pulmonary hypertension care.
